T Rowe PR Health Science-InvPRHSX
13F holders, Q1 2024 (March 31)6holders
$94.52avg. 13F price*
At the end of Q1 2024, 6 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings. The largest holders were Ethos Financial Group, LLC ($251K), Westside Investment Management, Inc. ($138K) and Coston, McIsaac & Partners ($80K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $56K |
| Exits | 3 | $10.4M |
Ownership 6 holders
| Ethos Financial Group, LLC | 0.05% | No change | 2,642 | $251K |
| Westside Investment Management, Inc. | 0.03% | No change | 1,467 | $138K |
| Coston, McIsaac & Partners | 0.03% | No change | 849 | $80K |
| Laffer Tengler Investments, Inc. | 0.02% | New | 586 | $56K |
| Financial Gravity Asset Management, Inc. | 0.00% | Reduce -94.8% | 99 | $9K |
| Tucker Asset Management LLC | 0.00% | No change | 27 | $3K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.